CFP and infection: Sublethal chlorfenapyr dose induced significantly lower prevalence of infection than the lower anti-malarial dose (6.6% [2.7–14.9] for CFP vs. 24% [16.1–34.9] for A/L, OR [95% CI] = 0.22 [0.06–0.7], p < 0.012) (Fig. 4).